24
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Menarche and subsequent ovarian function in girls with congenital adrenal hyperplasia.

      Hormone research
      Adolescent, Adrenal Hyperplasia, Congenital, drug therapy, physiopathology, Child, Dexamethasone, therapeutic use, Dose-Response Relationship, Drug, Female, Humans, Hydrocortisone, Menarche, Ovary, Ovulation, Progesterone, metabolism, Saliva, Testosterone, blood

      Read this article at

      ScienceOpenPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The mean age at menarche in 6 girls on treatment for congenital adrenal hyperplasia from infancy was 13.6 years (range 12.6-14.5 years). Menarche or regular menses did not occur until plasma testosterone concentrations were within normal limits. This was achieved using single daily dexamethasone, 0.25-0.75 mg/day. The potency of this glucocorticoid in suppressing adrenal steroid biosynthesis relative to cortisol is about 80:1. The onset of regular, ovulatory menstrual cycles, as judged by daily salivary progesterone profiles, was achieved within 2-3 years of menarche using this treatment regimen. Such patients have a good prognosis for normal fertility.

          Related collections

          Author and article information

          Comments

          Comment on this article